Hims & Hers Health (HIMS) Other Non Operating Income (2020 - 2026)
Hims & Hers Health (HIMS) reported Other Non Operating Income of $4.1 million for Q1 2026, up 57.81% on a YoY basis from $2.6 million in Q1 2025, and down 35.52% sequentially from $6.4 million in Q4 2025.
Hims & Hers Health (HIMS) Other Non Operating Income (2020 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 7 years of Other Non Operating Income data on file, last reported at $4.1 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 57.81% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $21.1 million (up 112.99% YoY), and the FY2025 full-year result was $23.1 million, up 135.82% from the prior year.
- Other Non Operating Income eased to $4.1 million in Q1 2026, from $6.4 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $8.0 million in Q3 2025 to a low of $320000.0 in Q1 2022.
- A 5-year average of $2.7 million and a median of $2.3 million in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income jumped 1115.2% in 2022 and sank 45.24% in 2024, its largest moves.
- Tracing HIMS's Other Non Operating Income over 5 years: stood at $1.5 million in 2022, then surged by 72.15% to $2.6 million in 2023, then jumped by 41.3% to $3.7 million in 2024, then surged by 72.1% to $6.4 million in 2025, then sank by 35.52% to $4.1 million in 2026.
- Business Quant data shows HIMS's Other Non Operating Income at $4.1 million in Q1 2026, $6.4 million in Q4 2025, and $8.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.10 Mn |
| Dec 31, 2025 | 6.36 Mn |
| Sep 30, 2025 | 8.04 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 677,000.00 |
| Jun 30, 2022 | 402,000.00 |
| Mar 31, 2022 | 320,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 219,000.00 |
| Jun 30, 2021 | 325,000.00 |
| Mar 31, 2021 | -224,000.00 |